MDS Sequencing Project Cancer Cell
|Study ID||Alternative Stable ID||Type|
Myelodysplastic syndromes (MDS) are uncommon entities, heterogeneous clinically and cytogenetically. The aim of the present study is to determine genetic alteration in this subset of patients. Expected results: Identification of new aberrations and genetic markers in order to detect novel genes involved in MDS 5q-response to Lenalidomide's treatment.
Study Datasets 1 dataset.
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
Cancer exome reads consisting of FASTQ paired end reads from bone marrow samples
|Illumina HiSeq 2000||42|
Who archives the data?